Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/16/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/10/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
67 |
| 10/08/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/06/14 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 10/01/14 | 8-K | Current report filing |
|
5 | |
| 09/09/14 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
11 | |
| 08/25/14 | 8-K | Current report filing |
|
4 | |
| 07/28/14 | ARS | Annual report to security holders |
|
0 | |
| 07/18/14 | DEF 14A | Definitive proxy statements |
|
28 | |
| 07/14/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 |
